IMPELLA CP
Report
- Report Number
- 1220648-2024-25229
- Event Type
- Death
- Date Received
- December 31, 2024
- Date of Event
- December 14, 2024
- Report Date
- February 24, 2025
- Manufacturer
- ABIOMED, INC.
- Product Code
- OZD
- UDI-DI
- 04260113630280
- PMA / PMN Number
- P140003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THE INVESTIGATION FOR THE REPORTED VENTRICULAR FIBRILLATION (VF) HAS BEEN COMPLETED. THE DEVICE NOR SUFFICIENT CLINICAL INFORMATION WAS RETURNED FOR EVALUATION. AS THE NECESSARY INFORMATION WAS NOT PROVIDED, THE ROOT CAUSE OF THE VF WAS NOT DETERMINED. B.2 REVISED DATE OF DEATH AS IT WAS PREVIOUSLY ENTERED INCORRECTLY ON THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229. H.6 CODE 4617 WAS INADVERTENTLY OMITTED FROM THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229 AND WAS ADDED.
THE ROOT CAUSE OF THE INVESTIGATION FOR ARRHYTHMIAS SUCH AS ATRIAL FIBRILLATION (AF), VENTRICULAR FIBRILLATION, VENTRICULAR TACHYCARDIA, AND ATRIAL TACHYCARDIA COULD NOT BE DETERMINED WITHOUT ADDITIONAL CLINICAL INFORMATION OR A DEVICE RETURN. THEREFORE, THE ROOT CAUSE OF THE AF ALSO COULD NOT BE DETERMINED WITHOUT ADDITIONAL INFORMATION. B.5 THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229 STATED THAT THE PATIENT EXPERIENCED VENTRICULAR FIBRILLATION (VF). HOWEVER, THE CORRECT ADVERSE EVENT SHOULD HAVE BEEN NOTED AS ATRIAL FIBRILLATION (AF). D.3 REVISED US ZIP CODE AS IT WAS INADVERTENTLY OMITTED ON THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229, H.6 CLINICAL CODE CHANGED FROM 2130 ON THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229 TO CODE 1729 DUE TO INFORMATION MENTIONED ABOVE IN B.5 CORRECTIONS. H.10 THE COMPLETED INVESTIGATION IN THE INITIAL MANUFACTURER DEVICE REPORT NUMBER 1220648-2024-25229 WAS FOR VF. THE INVESTIGATION HAS BEEN UPDATED TO INCLUDE AF INSTEAD OF VF.
THE IMPELLA DEVICE WAS NOT RECEIVED FROM THE CUSTOMER AND THEREFORE, AN EVALUATION OF THE DEVICE WAS NOT POSSIBLE. UPON INVESTIGATION CLOSURE, A SUPPLEMENTAL MDR WILL BE FILED.
THE USER FACILITY REPORTED A PATIENT (UNKNOWN RACE AND ETHNICITY) UNDERGOING A HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION WAS IMPLANTED WITH AN IMPELLA CP DEVICE FOR MECHANICAL CIRCULATORY SUPPORT AND THE FOLLOWING DAY AFTER START OF SUPPORT, THE PATIENT EXPERIENCED VENTRICULAR FIBRILLATION AND RECEIVED CARDIOVERSION MULTIPLE TIMES. THE POSITION OF THE PUMP WAS CORRECTED, AND THE PATIENT WAS REPORTED TO BE STABLE WHILE ON IMPELLA SUPPORT. UPDATE A COUPLE OF DAYS LATER NOTED, THE PATIENT STILL SEDATED AND INTUBATED WITH THE NEED FOR CATECHOLAMINES FOR WHAT THE PHYSICIAN CONSIDERS THE CAUSE COULD BE SEPTIC STATUS. VITAL SIGNS ARE STABLE AND THE IMPELLA WAS NOTED WORKING WITHOUT ANY PROBLEMS. FOLLOWING IT WAS NOTED CATECHOLAMINES ARE SLOWING BEING REDUCED AND THE PATIENT IS NOW ON DIALYSIS. NOW DAY FIVE OF SUPPORT, THE PHYSICIAN NOTED THE FIRST SIGNIFICANT RECOVERY SIGNS WITH LESS NEED FOR CATECHOLAMINES. ACCORDING TO THE PHYSICIAN'S REPORT, NEPHROLOGICAL STATUS IS SLOWLY RECOVERING DUE TO PERMANENT DIALYSIS. NO ISSUES WERE NOTED WITH THE IMPELLA CP DEVICE. THE FOLLOWING DAY SLOW WEANING STARTED. HOWEVER, THEREAFTER, NOW SEVEN DAYS AFTER START OF SUPPORT IT WAS NOTED THE PATIENT EXPIRED DUE TO AN "OVERALL BAD" HEALTH STATE. ALTHOUGH NOTED THE PATIENT EXPIRED DAYS LATER FROM "OVERALL BAD" HEATH STATE, THE IMPELLA DEVICE CANNOT BE EXCLUDED AS A POSSIBLE CONTRIBUTING FACTOR WHEN CONSIDERING THE IMPELLA-RELATED VENTRICULAR FIBRILLATION EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1090482 | IMPELLA CP | TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP | OZD | ABIOMED, INC. | IMPELLA CP | 2025535848 | 04260113630280 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Female | Death| R| L |